NCT03667339

Brief Summary

The main objective is to show that cumulative length of stay over the first 45 post operative days (i.e. : primary length of stay and readmission) is significantly lower in the outpatients group than in the inpatients group

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
Last Updated

April 13, 2023

Status Verified

April 1, 2023

Enrollment Period

1 month

First QC Date

September 10, 2018

Last Update Submit

April 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cumulative lenght of stay

    Cumulative lenght of stay ( ie : the sum of the days of hospitalization corresponding to the initial hospitalization and readmissions if there are any)

    45 days before surgery

Study Arms (2)

outpatients group

Patient schedulded to undergo outpatient Direct Anterior Total Hip Arthroplasty

Procedure: Direct Anterior Total Hip Arthroplasty

inpatients group

Patient schedulded to undergo inpatient Direct Anterior Total Hip Arthroplasty

Procedure: Direct Anterior Total Hip Arthroplasty

Interventions

Direct Anterior Total Hip Arthroplasty

inpatients groupoutpatients group

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with Direct Anterior Total Hip Arthroplasty

You may qualify if:

  • Unilateral primary total hip arthroplasty for hip osteoarthritis, primary or secondary osteoarthritis (dysplasia or post-traumatic) or osteonecrosis
  • Good enough understanding of outpatient management and patient adherence to post-operative instructions
  • Sufficient patient complicance to medical orders
  • Living and hygiene conditions, at least, equivalent to the ones the hospital provides
  • To be of age
  • Non opposition to the protocole participation
  • Outpatients group :
  • \- Patient schedulded to undergo outpatient THA
  • Inpatients group :
  • \- Patient schedulded to undergo inpatient THA because of not fiting the following items :
  • Less than an hour distance of a Health Center that provides appropriate care with regard to the surgery
  • Rapid access to a phone
  • Designated driver and caretaker available (at least the first night after discharge from the hospital) after the procedure Or turning down outpatient THA

You may not qualify if:

  • Anaesthetic point of view :
  • ASA physical status ≥ 3 and : unstabilize disease with appropriate treatment or lack of preoperative mutual agreement between anesthesiologist and surgeon or not inconsiderable interaction between the operation and the disease or its treatment
  • Pre-operative Hb \< 12 (♀) \< 13 (♂) g/L (NB : no Hb control before discharge except if excessive blood loss ; Hb \< 10g/L contraindicates outpatient surgery)
  • Opioid chronic pre-operative therapy or opioid addiction
  • Surgical point of view :
  • Ambulatory pre-operative status requiring use of two crutches or walking frame / distance walked \< 30 m
  • THA procedure for femoral neck fracture requiring
  • Additional operative technic needed
  • Adult safeguarding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rennes

Rennes, 35 033, France

Location

Study Officials

  • Jean Louis POLARD, MD

    Rennes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 12, 2018

Study Start

March 27, 2018

Primary Completion

May 10, 2018

Study Completion

May 10, 2018

Last Updated

April 13, 2023

Record last verified: 2023-04

Locations